PBAC Public Summary Documents – November 2023
Page last updated: 26 March 2024
Public Summary Documents relating to the November 2023 PBAC meeting.
- Abemaciclib: Tablet 50 mg, Tablet 100 mg, Tablet 150 mg; Verzenio®
- Adalimumab: Injection 40 mg in 0.4 mL pre-filled syringe, Injection 40 mg in 0.4 mL pre-filled pen; Hadlima®
- Apremilast: Tablet 30 mg, Pack containing 4 tablets 10 mg, 4 tablets 20 mg and 19 tablets 30 mg; Otezla®
- Budesonide + Formoterol: Powder for oral inhalation in breath actuated device containing budesonide 200 micrograms with formoterol fumarate dihydrate 6 micrograms per dose, 60 doses, Powder for oral inhalation in breath actuated device containing budesonide 400 micrograms with formoterol fumarate dihydrate 12 micrograms per dose, 60 doses; Bufomix® Easyhaler®
- Cabozantinib: Tablet 20 mg, Tablet 40 mg, Tablet 60 mg: Cabometyx®
- Cemiplimab: Solution for I.V. infusion 350 mg in 7 mL; Libtayo®
- Chlormethine hydrochloride: Gel 160 micrograms per g, 60 g; Ledaga®
- Cladribine: Tablet 10 mg; Mavenclad®
- Daunorubicin With Cytarabine: Powder for I.V infusion containing daunorubicin 44 mg and cytarabine 100 mg; Vyxeos®
- Difelikefalin: Solution for I.V. injection 50 micrograms in 1 mL vial; Korsuva®
- Dostarlimab: Solution concentrate for I.V. infusion 500 mg in 10 mL; Jemperli®
- Review of the Cost-Effectiveness of Drugs for Atopic Dermatitis: Dupilumab: Injection 200 mg in 1.14 mL single dose pre-filled syringe, Injection 300 mg in 2 mL single dose pre-filled syringe; Dupixent®; and Upadacitinib: Tablet 15 mg, Tablet 30 mg; Rinvoq®
- Edaravone: Solution concentrate for injection 30 mg in 20 mL; Radicava®
- Eltrombopag: Tablet 25 mg, Tablet 50 mg; Revolade®
- Empagliflozin: Tablet 10 mg; Jardiance®
- Fluticasone Propionate + Salmeterol: Powder for oral inhalation in breath actuated device containing fluticasone propionate 250 micrograms with salmeterol 50 micrograms (as xinafoate) per dose, 60 doses, Powder for oral inhalation in breath actuated device containing fluticasone propionate 500 micrograms with salmeterol 50 micrograms (as xinafoate) per dose, 60 doses; Salflumix® Easyhaler®
- Icosapent Ethyl: Capsule 1 g; Vazkepa®
- Ivacaftor: Sachet containing granules 25 mg, Sachet containing granules 50 mg, Sachet containing granules 75 mg, Tablet 150 mg; Kalydeco®
- Lenacapavir: Injection set containing 2 vials lenacapavir sodium solution for injection 463.5 mg in 1.5 mL and 2 disposable syringes; Sunlenca®
- Lenalidomide: Capsule 20 mg; Lenalide®
- Maribavir: Tablet 200 mg; Livtencity®
- Mavacamten: Capsule 2.5 mg, Capsule 5 mg, Capsule 10 mg, Capsule 15 mg; Camzyos®
- Medroxyprogesterone acetate: Suspension for injection 150 mg in 1 mL pre-filled syringe; Depo-Provera®
- Meningococcal vaccine: Injection 0.5 mL; Menveo®
- Midazolam: Oromucosal solution in pre-filled syringe 2.5 mg in 0.25 mL, Oromucosal solution in pre-filled syringe 5 mg in 0.5 mL, Oromucosal solution in pre-filled syringe 7.5 mg in 0.75 mL, Oromucosal solution in pre-filled syringe 10 mg in 1 mL; Zyamis®
- Nirmatrelvir and ritonavir: Pack containing 4 tablets nirmatrelvir 150 mg and 2 tablets ritonavir 100 mg, 5; Paxlovid®
- Nivolumab: Injection concentrate for I.V. infusion 40 mg in 4 mL, Injection concentrate for I.V. infusion 100 mg in 10 mL; Opdivo®
- Olaparib (breast cancer): Tablet 100 mg, Tablet 150 mg; Lynparza®
- Olaparib (prostate cancer): Tablet 100 mg, Tablet 150 mg; Lynparza®
- Osimertinib: Tablet 40 mg, Tablet 80 mg; Tagrisso®
- Oxybutynin: Transdermal patches 36 mg, 8; Oxytrol®
- Pembrolizumab: Solution concentrate for I.V. infusion 100 mg in 4 mL; Keytruda®
- Pneumococcal Conjugate Vaccine, 20-Valent : 0.5 mL pre-filled syringe; Prevenar 20®
- Risankizumab: Injection 150 mg in 1 mL pre-filled syringe, Injection 150 mg in 1 mL pre-filled pen; Skyrizi®
- Sacituzumab Govitecan: Powder for injection 180 mg; Trodelvy®
- Secukinumab: Solution for injection 300 mg in 2 mL pre-filled syringe, Solution for injection 150 mg in 1 mL pre-filled syringe, Solution for injection 150 mg in 1 mL pre-filled pen, Solution for injection 300 mg in 2 mL pre-filled pen; Cosentyx®
- Semaglutide: Injection 0.25 mg in 0.5 mL pre-filled single dose pen, Injection 0.5 mg in 0.5 mL pre-filled single dose pen, Injection 1.0 mg in 0.5 mg pre-filled single dose pen, Injection 1.7 mg in 0.75 mL pre-filled single dose pen, Injection 2.4 mg in 0.75 mL pre-filled single dose pen; Wegovy®
- Teriparatide: Injection 250 micrograms per mL, 2.4 mL in multi-dose pre-filled pen; Teriparatide Lupin
- Teriparatide: Injection 250 micrograms per mL, 2.4 mL in multi-dose pre-filled pen; Terrosa®
- Trastuzumab Deruxtecan: Powder for I.V. infusion 100 mg; Enhertu®
- Varicella Zoster Virus Recombinant Vaccine: Injection 1 vial & adjuvant substance diluent 0.5 mL vial; Shingrix®
The following Public Summary Documents have been updated:
